Nevertheless, in order to be useful as biomarkers in sepsis, any method for measuring HLA-DRA and CIITA, expressed as a ratio to a reference gene, in this case peptidylpropylisomerase gene (PPIB), should be validated regarding its robustness during the course of sepsis. This evidence concerns the gene CIITA and Sepsis.